Fusion event
HBV-SHLD2P3 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
End
47371579/47681559 (Hg38)
Nearest miRNA
hsa-mir-1265/Upstream/2517471; hsa-mir-107/Downstream/1303953;
Upstream sequence
CCCCTGGCACCTACCTGTGAGTTCATGATTACTAGTCTTAAAGTTCAGTCCTTTTTATTTTTACtttttttttttttttttttttttttagagacagtgt
Downstream sequence
ctcactctgtcatccaggctggagtgcagtggcacaatcacggcttactgtagccttgatctcccaggctcaggtgatcctttcacttcagcctcctgag
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.